Three papers
by Gladys Ouedraogo
- C Alexander-White, D Bury, M Cronin, M Dent, E Hack, NJ Hewitt, G Kenna, J Naciff, G Ouedraogo, A Schepky, C Mahony, and C Europe. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment. Regul Toxicol Pharmacol 129 : 105094 (Mar 4, 2022). [abstract] [pubmed]
- D Bury, C Alexander-White, HJ Clewell, M Cronin, B Desprez, A Detroyer, J Firman, E Hack, NJ Hewitt, G Kenna, M Klaric, C Lester, C Mahony, G Ouedraogo, A Paini, A Schepky, , and AY Efremenko. New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine. Regul Toxicol Pharmacol 123 : 104931 (Apr 24, 2021). [abstract] [pubmed]
- L Truong, G Ouedraogo, L Pham, J Clouzeau, S Loisel-Joubert, D Blanchet, H Noçairi, W Setzer, R Judson, C Grulke, K Mansouri, and M Martin. Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates. Arch Toxicol 92 (2) : 587-600 (Feb 27, 2018). [abstract] [pubmed]